A Study to Evaluate the Safety and Efficacy of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Participants With High Grade Primary Central Nervous System (CNS) Malignancies
Clinical trial NCT03130959 · COMPLETED
Trial details
- NCT number
- NCT03130959
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-12
- Primary completion
- 2020-03-10
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.